Analysis of inflammatory markers and electroencephalogram findings in paediatric patients with COVID-19: a single-centre study in Korea
preprint
OA: gold
CC-BY-4.0
Abstract
A big infectious wave overwhelmingly spread from February 2022 in South Korea after the COVID-19 outbreak was managed. Therefore, we analysed electroencephalogram (EEG) findings and serologic inflammatory markers in pediatric patients with COVID-19 by retrospectively reviewing medical records of 41 patients who visited Gyeongsang National University Changwon Hospital from March to May 2022 and were diagnosed with COVID-19; all serologic tests were performed within 24 hours after presenting with fever or seizure. The median patient age and average number of hospitalisation days were 3.6 (0.08–14.00) years and 3.71 (1.0–7.0) days, respectively. Interleukin-6 (IL-6) were elevated above the normal range in all patients (median value, 43.18 [7.0–190.0] pg/ml) and were higher among patients with seizures. Among 41 patients, 17 (41.5%) with a mean age of 5.4 years had higher complaints of seizures. Three patients had prolonged seizures for > 30 minutes and received intravenous lorazepam injections and eight had a complex type of febrile convulsion. Nine patients underwent EEG, and five showed abnormal findings in the initial EEG. In the linear regression model, serum IL-6 and blood lymphocyte counts were correlated with prolonged seizure duration. These findings underscore that several immune cascade-related serologic markers were elevated in children with COVID-19-related febrile seizures. We may assume that COVID-19 presents similarities and differences in the mechanisms that provoke seizures and fever in children.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (43)
- Multi-organ impairment and Long COVID: a 1-year prospective, longitudinal cohort study via crossref
- doi:10.3346/jkms.2022.37.e31 via crossref
- doi:10.3233/jad-200581 via crossref
- doi:10.3390/children7070069 via crossref
- doi:10.1111/apa.16276 via crossref
- doi:10.1111/j.1528-1167.2008.01963.x via crossref
- doi:10.1080/22221751.2022.2093135 via crossref
- doi:10.1111/dmcn.14642 via crossref
- doi:10.1093/tropej/fmab062 via crossref
- doi:10.1111/epi.17293 via crossref
- doi:10.1515/revneuro-2020-0070 via crossref
- doi:10.1111/epi.16656 via crossref
- doi:10.1111/nan.12662 via crossref
- doi:10.1016/j.cegh.2021.100727 via crossref
- doi:10.3389/fped.2020.607647 via crossref
- doi:10.1006/viro.2000.0442 via crossref
- doi:10.1016/j.clim.2008.08.018 via crossref
- doi:10.7554/elife.01949 via crossref
- doi:10.1016/j.neulet.2004.04.061 via crossref
- doi:10.1016/j.jneuroim.2017.12.008 via crossref
- doi:10.1016/j.msard.2020.102535 via crossref
- doi:10.7748/ncyp.27.2.20.e497 via crossref
- doi:10.1111/j.1528-1167.2005.00294.x via crossref
- doi:10.7326/0003-4819-112-1-3%m via crossref
- doi:10.1186/s12887-016-0740-5 via crossref
- doi:10.1007/s10096-019-03514-1 via crossref
- doi:10.1182/blood.v73.1.108.108 via crossref
- doi:10.1016/0987-7053(96)89627-4 via crossref
- doi:10.1080/00029238.1990.11080344 via crossref
- doi:10.1055/s-0028-1091777 via crossref
- doi:10.1007/bf00346164 via crossref
- doi:10.1007/bf00438932 via crossref
- doi:10.1515/revneuro-2020-0116 via crossref
- doi:10.1038/s41593-020-00758-5 via crossref
- doi:10.1038/s41467-018-05131-6 via crossref
- doi:10.1002/cne.902080208 via crossref
- doi:10.3389/fncel.2021.649262 via crossref
- doi:10.1002/hipo.22129 via crossref
- doi:10.4049/jimmunol.173.6.4030 via crossref
- doi:10.3345/kjp.2018.61.5.135 via crossref
- doi:10.1111/epi.13709 via crossref
- doi:10.1007/s15010-020-01516-2 via crossref
- doi:10.1016/j.cnp.2017.07.002 via crossref
Source provenance
- crossref
- last seen: 2026-07-10T06:41:15.669831+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-05-21T02:00:01.467718+00:00
License: CC-BY-4.0